Transportation by HEMS resulted in a significant survival benefit compared to GEMS patients despite increased injury severity and incidence of posttraumatic complications (MODS, sepsis).
The accuracy of prehospital documented diagnoses was not increased in HEMS compared to GEMS rescue.
The extent of preclinical management was more extensive in HEMS resulting in prolonged on-scene times.
HEMS patients were more often admitted to level I trauma centers.
SOURCE BIOMED CENTRAL – Prehospital trauma care is still a matter of ongoing debate with inconsistent evidence comparing the impact of helicopter and ground emergency transport on outcome of traumatized patients. We performed a study comparing the effects of HEMS and GEMS on outcome after trauma. We were able to demonstrate that transportation by HEMS resulted in a significant survival benefit compared to GEMS patients despite increased injury severity and incidence of posttraumatic complications (MODS, sepsis). Sensitivity and specificity of preclinical diagnoses were not superior in HEMS compared to GEMS. The extent of preclinical management was more extensive in HEMS resulting in prolonged on-scene times. Finally, HEMS patients were more often admitted to level I trauma centers.
Abstract Introduction: Physician-staffed helicopter emergency medical services (HEMS) are a well-established component of prehospital trauma care in Germany. Reduced rescue times and increased catchment area represent presumable specific advantages of HEMS. In contrast, the availability of HEMS is connected to a high financial burden and depends on the weather, day time and controlled visual flight rules. To date, clear evidence regarding the beneficial effects of HEMS in terms of improved clinical outcome has remained elusive.
Methods: Traumatized patients (Injury Severity Score; ISS ≥9) primarily treated by HEMS or ground emergency medical services (GEMS) between 2007 and 2009 were analyzed using the TraumaRegister DGU® of the German Society for Trauma Surgery. Only patients treated in German level I and II trauma centers with complete data referring to the transportation mode were included. Complications during hospital treatment included sepsis and organ failure according to the criteria of the American College of Chest Physicians/Society of Critical Care Medicine (ACCP/SCCM) consensus conference committee and the Sequential Organ Failure Assessment (SOFA) score.
Results: A total of 13,220 patients with traumatic injuries were included in the present study. Of these, 62.3% (n = 8,231) were transported by GEMS and 37.7% (n = 4,989) by HEMS. Patients treated by HEMS were more seriously injured compared to GEMS (ISS 26.0 vs. 23.7, P < 0.001) with more severe chest and abdominal injuries. The extent of medical treatment on-scene, which involved intubation, chest and treatment with vasopressors, was more extensive in HEMS (P < 0.001) resulting in prolonged on-scene time (39.5 vs. 28.9 minutes, P < 0.001). During their clinical course, HEMS patients more frequently developed multiple organ dysfunction syndrome (MODS) (HEMS: 33.4% vs. GEMS: 25.0%; P < 0.001) and sepsis (HEMS: 8.9% vs. GEMS: 6.6%, P < 0.001) resulting in an increased length of ICU treatment and in-hospital time (P < 0.001). Multivariate logistic regression analysis found that after adjustment by 11 other variables the odds ratio for mortality in HEMS was 0.75 (95% CI: 0.636 to 862). Afterwards, a subgroup analysis was performed on patients transported to level I trauma centers during daytime with the intent of investigating a possible correlation between the level of the treating trauma center and posttraumatic outcome. According to this analysis, the Standardized Mortality Ratio, SMR, was significantly decreased following the Trauma Score and the Injury Severity Score (TRISS) method (HEMS: 0.647 vs. GEMS: 0.815; P = 0.002) as well as the Revised Injury Severity Classification (RISC) score (HEMS: 0.772 vs. GEMS: 0.864; P = 0.045) in the HEMS group.
Conclusions: Although HEMS patients were more seriously injured and had a significantly higher incidence of MODS and sepsis, these patients demonstrated a survival benefit compared to GEMS.
SEE THE PDF HERE
[document url=”http://download.springer.com/static/pdf/993/art%253A10.1186%252Fcc12796.pdf?originUrl=http%3A%2F%2Fccforum.biomedcentral.com%2Farticle%2F10.1186%2Fcc12796&token2=exp=1460551607~acl=%2Fstatic%2Fpdf%2F993%2Fart%25253A10.1186%25252Fcc12796.pdf*~hmac=b5961cd0fcacc06a61013ad8f5a2dc1ab7e76e8cebab4c6fa42af008bb88288e” width=”600″ height=”760″]